Your session is about to expire
← Back to Search
PrEP Behavioral Intervention for HIV/AIDS Prevention (PrEP Trial)
N/A
Recruiting
Led By Angela Bazzi, PhD, MPH
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Not currently on and never taken PrEP
Able to understand and speak English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
PrEP Trial Summary
This trial will test a behavioral intervention to improve the use of an HIV prevention medication among people who inject drugs.
Who is the study for?
This trial is for people who inject drugs, are at risk for HIV, have never taken PrEP (a medication to prevent HIV), and engage in behaviors like sharing needles or having unprotected sex. Participants must not be on PrEP currently, understand English or Spanish, and plan to stay in Massachusetts for at least a year.Check my eligibility
What is being tested?
The study tests 'PrEP for Health,' which includes education about HIV/PrEP, motivational talks, planning help, and patient navigation versus just getting information and referrals. The goal is to see if the program helps participants start and stick with PrEP over time by checking drug levels in their hair.See study design
What are the potential side effects?
Since this trial focuses on behavioral interventions rather than medications directly provided by researchers, side effects are minimal. However, standard side effects of taking PrEP may include nausea, headache, stomach pain, weight loss but these will depend on individual reactions once they begin the medication.
PrEP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have never taken PrEP.
Select...
I can understand and speak English or Spanish.
PrEP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Post-treatment PrEP adherence
PrEP uptake
Secondary outcome measures
Longer-term PrEP adherence
PrEP Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PrEP for healthExperimental Treatment5 Interventions
Participants in the PrEP (pre-exposure prophylaxis) for health arm will receive theory informed HIV and PrEP education, motivational interviewing, problem-solving and planning, and ongoing patient navigation.
Group II: Standard of careActive Control2 Interventions
Participants in the standard of care arm will receive PrEP information and referrals.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient navigation
2019
N/A
~1740
Motivational interviewing
2011
Completed Phase 3
~7250
Find a Location
Who is running the clinical trial?
University of California, San DiegoOTHER
1,121 Previous Clinical Trials
1,520,724 Total Patients Enrolled
AIDS Action Committee of MassachusettsOTHER
1 Previous Clinical Trials
574 Total Patients Enrolled
Greater Lawrence Family Health CenterUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have never taken PrEP.I can understand and speak English or Spanish.You have injected any drugs within the last month.
Research Study Groups:
This trial has the following groups:- Group 1: PrEP for health
- Group 2: Standard of care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals have enrolled in this research endeavor?
"Affirmative. Clinicaltrials.gov data confirms that this medical examination is actively recruiting for participants, with an initial posting on September 2nd 2021 and a recent update on May 20th 2022. The trial requires 200 individuals to be recruited from two separate sites."
Answered by AI
Is enrollment open to new participants in this clinical trial?
"Verified by clinicaltrials.gov, this medical trial is still recruiting individuals to participate. Initially posted on September 2nd 2021 and recently edited on May 20th 2022."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger